BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
575615	OC[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnn[nH]1)C(O)=O |r|	InChI=1S/C21H22N4O4/c26-13-17(21(28)29)11-18(23-20(27)19-12-22-25-24-19)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,12,17-18,26H,10-11,13H2,(H,23,27)(H,28,29)(H,22,24,25)	BFRRLPZTJYBXMG-UHFFFAOYSA-N	300705	2S,4S)-5-Biphenyl-4-yl-2-hydroxymethyl-4-[(3H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid::US10130642, Example 1B	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300705	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300705&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			60163871	381749465							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575616	OC[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nc(Cl)n[nH]1)C(O)=O |r|	InChI=1S/C21H21ClN4O4/c22-21-24-18(25-26-21)19(28)23-17(11-16(12-27)20(29)30)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,16-17,27H,10-12H2,(H,23,28)(H,29,30)(H,24,25,26)	GXIKQEOKIRNKBD-UHFFFAOYSA-N	300706	(2S,4S)-5-Biphenyl-4-yl-4-[(5-chloro-2H-[1,2,4]-triazole-3-carbonyl)-amino]-2-hydroxymethyl-pentanoic acid::US10130642, Example 2A	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300706	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300706&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68181230	381749466							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575617	OC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1nc(Cl)n[nH]1)C(O)=O |r|	InChI=1S/C21H20ClFN4O4/c22-21-25-18(26-27-21)19(29)24-17(10-15(11-28)20(30)31)8-12-4-6-13(7-5-12)14-2-1-3-16(23)9-14/h1-7,9,15,17,28H,8,10-11H2,(H,24,29)(H,30,31)(H,25,26,27)	WMIDDCHRAIMDGR-UHFFFAOYSA-N	300707	(2S,4S)-4-[(5-Chloro-2H-[1,2,4]triazole-3-carbonyl)amino]-5-(3&#8242;-fluorobiphenyl-4-yl)-2-hydroxymethyl-pentanoic acid::US10130642, Example 3B	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300707	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300707&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68181140	381749467							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575618	OCC(CC(Cc1ccccc1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C15H18N4O4/c20-9-11(15(22)23)7-12(6-10-4-2-1-3-5-10)17-14(21)13-8-16-19-18-13/h1-5,8,11-12,20H,6-7,9H2,(H,17,21)(H,22,23)(H,16,18,19)	FRGNVYHHQXTCFC-UHFFFAOYSA-N	300708	US10130642, Example 4-1	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300708	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300708&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553940	381749468							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575619	OCC(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C21H21FN4O4/c22-18-4-2-1-3-17(18)14-7-5-13(6-8-14)9-16(10-15(12-27)21(29)30)24-20(28)19-11-23-26-25-19/h1-8,11,15-16,27H,9-10,12H2,(H,24,28)(H,29,30)(H,23,25,26)	KGZXIAYXBPPXNH-UHFFFAOYSA-N	300709	US10130642, Example 4-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300709	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300709&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553941	381749469							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575620	OCC(CC(Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C21H21FN4O4/c22-17-3-1-2-15(9-17)14-6-4-13(5-7-14)8-18(10-16(12-27)21(29)30)24-20(28)19-11-23-26-25-19/h1-7,9,11,16,18,27H,8,10,12H2,(H,24,28)(H,29,30)(H,23,25,26)	CLFXWNBQSUGZQK-UHFFFAOYSA-N	300710	US10130642, Example 4-3	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300710	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300710&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553942	381749470							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575621	OCC(CC(Cc1ccccc1)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C15H18N4O5/c20-9-11(15(22)23)7-12(6-10-4-2-1-3-5-10)16-14(21)13-8-19(24)18-17-13/h1-5,8,11-12,20,24H,6-7,9H2,(H,16,21)(H,22,23)	ADKWGSHMRHHABB-UHFFFAOYSA-N	300711	US10130642, Example 4-7	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300711	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300711&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553943	381749471							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575622	OCC(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C21H21FN4O5/c22-18-4-2-1-3-17(18)14-7-5-13(6-8-14)9-16(10-15(12-27)21(29)30)23-20(28)19-11-26(31)25-24-19/h1-8,11,15-16,27,31H,9-10,12H2,(H,23,28)(H,29,30)	SIYGAEYCKFDCJW-UHFFFAOYSA-N	300712	US10130642, Example 4-8	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300712	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300712&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			72669906	381749472							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575623	OCC(CC(Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C21H21ClN4O4/c22-17-3-1-2-15(9-17)14-6-4-13(5-7-14)8-18(10-16(12-27)21(29)30)24-20(28)19-11-23-26-25-19/h1-7,9,11,16,18,27H,8,10,12H2,(H,24,28)(H,29,30)(H,23,25,26)	MHLIIOKYKNPVEU-UHFFFAOYSA-N	300713	US10130642, Example 4-9	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300713	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300713&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			72669903	381749473							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575624	OCC(CC(Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C21H21ClN4O5/c22-17-3-1-2-15(9-17)14-6-4-13(5-7-14)8-18(10-16(12-27)21(29)30)23-20(28)19-11-26(31)25-24-19/h1-7,9,11,16,18,27,31H,8,10,12H2,(H,23,28)(H,29,30)	JOZYSZQZYSGLCV-UHFFFAOYSA-N	300714	US10130642, Example 4-10	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300714	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300714&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			77419060	381749474							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575625	OCC(CC(Cc1ccccc1)NC(=O)c1nc[nH]n1)C(O)=O	InChI=1S/C15H18N4O4/c20-8-11(15(22)23)7-12(6-10-4-2-1-3-5-10)18-14(21)13-16-9-17-19-13/h1-5,9,11-12,20H,6-8H2,(H,18,21)(H,22,23)(H,16,17,19)	JUHMAILOHXAHFY-UHFFFAOYSA-N	300715	US10130642, Example 4-11	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300715	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300715&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553944	381749475							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575626	OCC(CC(Cc1ccccc1)NC(=O)c1ncn[nH]1)C(O)=O	InChI=1S/C15H18N4O4/c20-8-11(15(22)23)7-12(6-10-4-2-1-3-5-10)18-14(21)13-16-9-17-19-13/h1-5,9,11-12,20H,6-8H2,(H,18,21)(H,22,23)(H,16,17,19)	JUHMAILOHXAHFY-UHFFFAOYSA-N	300716	US10130642, Example 4-12	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300716	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300716&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553944	381749476							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575627	Cc1n[nH]c(n1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C16H20N4O4/c1-10-17-14(20-19-10)15(22)18-13(8-12(9-21)16(23)24)7-11-5-3-2-4-6-11/h2-6,12-13,21H,7-9H2,1H3,(H,18,22)(H,23,24)(H,17,19,20)	LTIJEIVXBGODKF-UHFFFAOYSA-N	300717	US10130642, Example 4-13	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300717	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300717&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553945	381749477							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575628	OCC(CC(Cc1ccccc1)NC(=O)c1nc(O)n[nH]1)C(O)=O	InChI=1S/C15H18N4O5/c20-8-10(14(22)23)7-11(6-9-4-2-1-3-5-9)16-13(21)12-17-15(24)19-18-12/h1-5,10-11,20H,6-8H2,(H,16,21)(H,22,23)(H2,17,18,19,24)	SALFRMAVKBUTQB-UHFFFAOYSA-N	300718	US10130642, Example 4-14	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300718	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300718&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553946	381749478							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575629	CCOC(=O)C(CO)CC(Cc1ccccc1)NC(=O)c1nc(O)n[nH]1	InChI=1S/C17H22N4O5/c1-2-26-16(24)12(10-22)9-13(8-11-6-4-3-5-7-11)18-15(23)14-19-17(25)21-20-14/h3-7,12-13,22H,2,8-10H2,1H3,(H,18,23)(H2,19,20,21,25)	XYKFGJHBCCNTBD-UHFFFAOYSA-N	300719	US10130642, Example 4-15	Neprilysin	Human	 1000000000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300719	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300719&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553947	381749479							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575630	OCC(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1nc(Cl)n[nH]1)C(O)=O	InChI=1S/C21H20ClFN4O4/c22-21-25-18(26-27-21)19(29)24-15(10-14(11-28)20(30)31)9-12-5-7-13(8-6-12)16-3-1-2-4-17(16)23/h1-8,14-15,28H,9-11H2,(H,24,29)(H,30,31)(H,25,26,27)	GORQAYBICXGASI-UHFFFAOYSA-N	300720	US10130642, Example 4-16	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300720	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300720&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			72669944	381749480							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575631	OCC(CC(Cc1ccccc1)NC(=O)c1cc(O)n[nH]1)C(O)=O	InChI=1S/C16H19N3O5/c20-9-11(16(23)24)7-12(6-10-4-2-1-3-5-10)17-15(22)13-8-14(21)19-18-13/h1-5,8,11-12,20H,6-7,9H2,(H,17,22)(H,23,24)(H2,18,19,21)	KPJBEBVYOLLTKE-UHFFFAOYSA-N	300721	US10130642, Example 4-17	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300721	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300721&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553948	381749481							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575632	OCC(CC(Cc1ccccc1)NC(=O)c1cc(n[nH]1)C(O)=O)C(O)=O	InChI=1S/C17H19N3O6/c21-9-11(16(23)24)7-12(6-10-4-2-1-3-5-10)18-15(22)13-8-14(17(25)26)20-19-13/h1-5,8,11-12,21H,6-7,9H2,(H,18,22)(H,19,20)(H,23,24)(H,25,26)	XHJNVMIHKYSUPV-UHFFFAOYSA-N	300722	US10130642, Example 4-18	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300722	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300722&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553949	381749482							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575633	CC(=O)c1cc([nH]n1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C18H21N3O5/c1-11(23)15-9-16(21-20-15)17(24)19-14(8-13(10-22)18(25)26)7-12-5-3-2-4-6-12/h2-6,9,13-14,22H,7-8,10H2,1H3,(H,19,24)(H,20,21)(H,25,26)	OBRFTBCQRAMATG-UHFFFAOYSA-N	300723	US10130642, Example 4-19	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300723	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300723&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553950	381749483							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575634	CN(C)C(=O)c1cc([nH]n1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C19H24N4O5/c1-23(2)18(26)16-10-15(21-22-16)17(25)20-14(9-13(11-24)19(27)28)8-12-6-4-3-5-7-12/h3-7,10,13-14,24H,8-9,11H2,1-2H3,(H,20,25)(H,21,22)(H,27,28)	HMIUNXKQLROFIT-UHFFFAOYSA-N	300724	BDBM300725::US10130642, Example 4-20	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300724	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300724&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553951	381749484							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575635	CN(C)C(=O)c1cc([nH]n1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C19H24N4O5/c1-23(2)18(26)16-10-15(21-22-16)17(25)20-14(9-13(11-24)19(27)28)8-12-6-4-3-5-7-12/h3-7,10,13-14,24H,8-9,11H2,1-2H3,(H,20,25)(H,21,22)(H,27,28)	HMIUNXKQLROFIT-UHFFFAOYSA-N	300724	BDBM300725::US10130642, Example 4-20	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300724	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300724&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553951	381749484							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575636	COCCN(C)C(=O)c1cc([nH]n1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C21H28N4O6/c1-25(8-9-31-2)20(28)18-12-17(23-24-18)19(27)22-16(11-15(13-26)21(29)30)10-14-6-4-3-5-7-14/h3-7,12,15-16,26H,8-11,13H2,1-2H3,(H,22,27)(H,23,24)(H,29,30)	LXPVXTSUHNKBOQ-UHFFFAOYSA-N	300726	US10130642, Example 4-22	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300726	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300726&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553952	381749486							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575637	OCC(CC(Cc1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)NC1CC1)C(O)=O	InChI=1S/C20H24N4O5/c25-11-13(20(28)29)9-15(8-12-4-2-1-3-5-12)22-19(27)17-10-16(23-24-17)18(26)21-14-6-7-14/h1-5,10,13-15,25H,6-9,11H2,(H,21,26)(H,22,27)(H,23,24)(H,28,29)	DTYIWESMHZUVEV-UHFFFAOYSA-N	300727	US10130642, Example 4-23	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300727	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300727&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553953	381749487							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575638	OCC(CC(Cc1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCC1)C(O)=O	InChI=1S/C20H24N4O5/c25-12-14(20(28)29)10-15(9-13-5-2-1-3-6-13)21-18(26)16-11-17(23-22-16)19(27)24-7-4-8-24/h1-3,5-6,11,14-15,25H,4,7-10,12H2,(H,21,26)(H,22,23)(H,28,29)	GAODGPQBSXUCTH-UHFFFAOYSA-N	300728	US10130642, Example 4-24	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300728	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300728&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553954	381749488							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575639	OCC(CC(Cc1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCCC1)C(O)=O	InChI=1S/C21H26N4O5/c26-13-15(21(29)30)11-16(10-14-6-2-1-3-7-14)22-19(27)17-12-18(24-23-17)20(28)25-8-4-5-9-25/h1-3,6-7,12,15-16,26H,4-5,8-11,13H2,(H,22,27)(H,23,24)(H,29,30)	OKVRYZCFDULUJZ-UHFFFAOYSA-N	300729	US10130642, Example 4-25	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300729	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300729&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553955	381749489							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575640	OCC(CC(Cc1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCOCC1)C(O)=O	InChI=1S/C21H26N4O6/c26-13-15(21(29)30)11-16(10-14-4-2-1-3-5-14)22-19(27)17-12-18(24-23-17)20(28)25-6-8-31-9-7-25/h1-5,12,15-16,26H,6-11,13H2,(H,22,27)(H,23,24)(H,29,30)	YXBOWZKTAXGUSC-UHFFFAOYSA-N	300730	US10130642, Example 4-26	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300730	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300730&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553956	381749490							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575641	OCC(CC(Cc1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccccc1Cl)C(O)=O	InChI=1S/C22H22ClN3O4/c23-18-9-5-4-8-17(18)19-12-20(26-25-19)21(28)24-16(11-15(13-27)22(29)30)10-14-6-2-1-3-7-14/h1-9,12,15-16,27H,10-11,13H2,(H,24,28)(H,25,26)(H,29,30)	YRTSXWDGSSMMJC-UHFFFAOYSA-N	300731	US10130642, Example 4-27	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300731	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300731&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553957	381749491							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575642	CCCCc1cc([nH]n1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C20H27N3O4/c1-2-3-9-16-12-18(23-22-16)19(25)21-17(11-15(13-24)20(26)27)10-14-7-5-4-6-8-14/h4-8,12,15,17,24H,2-3,9-11,13H2,1H3,(H,21,25)(H,22,23)(H,26,27)	DGQYSBAIILROHZ-UHFFFAOYSA-N	300732	US10130642, Example 4-28	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300732	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300732&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553958	381749492							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575643	OCC(CC(Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1cc(n[nH]1)-c1ccccc1Cl)C(O)=O	InChI=1S/C28H25ClFN3O4/c29-24-7-2-1-6-23(24)25-15-26(33-32-25)27(35)31-22(14-20(16-34)28(36)37)12-17-8-10-18(11-9-17)19-4-3-5-21(30)13-19/h1-11,13,15,20,22,34H,12,14,16H2,(H,31,35)(H,32,33)(H,36,37)	KKBQPIBRFBCLEB-UHFFFAOYSA-N	300733	US10130642, Example 4-29	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300733	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300733&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			77419151	381749493							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575644	OCC(CC(Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1cc(n[nH]1)-c1ccccn1)C(O)=O	InChI=1S/C27H25FN4O4/c28-21-5-3-4-19(13-21)18-9-7-17(8-10-18)12-22(14-20(16-33)27(35)36)30-26(34)25-15-24(31-32-25)23-6-1-2-11-29-23/h1-11,13,15,20,22,33H,12,14,16H2,(H,30,34)(H,31,32)(H,35,36)	WREKHYVOAWZCGO-UHFFFAOYSA-N	300734	US10130642, Example 4-30	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300734	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300734&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553959	381749494							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575645	OCC(CC(Cc1ccccc1)NC(=O)C1=NCC(O)=N1)C(O)=O |c:20,t:16|	InChI=1S/C16H19N3O5/c20-9-11(16(23)24)7-12(6-10-4-2-1-3-5-10)18-15(22)14-17-8-13(21)19-14/h1-5,11-12,20H,6-9H2,(H,18,22)(H,23,24)(H,17,19,21)	IHYIPELQXXKVON-UHFFFAOYSA-N	300735	US10130642, Example 4-31	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300735	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300735&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553960	381749495							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575646	OCC(CC(Cc1ccccc1)NC(=O)c1cc(Cl)c2nn[nH]c2c1)C(O)=O	InChI=1S/C19H19ClN4O4/c20-15-8-12(9-16-17(15)23-24-22-16)18(26)21-14(7-13(10-25)19(27)28)6-11-4-2-1-3-5-11/h1-5,8-9,13-14,25H,6-7,10H2,(H,21,26)(H,27,28)(H,22,23,24)	RWXBCSIOCOUHLF-UHFFFAOYSA-N	300736	US10130642, Example 4-32	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300736	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300736&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553961	381749496							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575647	OCC(CC(Cc1ccccc1)NC(=O)c1cc(F)c2nn[nH]c2c1)C(O)=O	InChI=1S/C19H19FN4O4/c20-15-8-12(9-16-17(15)23-24-22-16)18(26)21-14(7-13(10-25)19(27)28)6-11-4-2-1-3-5-11/h1-5,8-9,13-14,25H,6-7,10H2,(H,21,26)(H,27,28)(H,22,23,24)	WLCJODRPSNIVPZ-UHFFFAOYSA-N	300737	US10130642, Example 4-33	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300737	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300737&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553962	381749497							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575648	OCC(CC(Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1ccc2nnn(O)c2c1)C(O)=O	InChI=1S/C25H23FN4O5/c26-20-3-1-2-17(11-20)16-6-4-15(5-7-16)10-21(12-19(14-31)25(33)34)27-24(32)18-8-9-22-23(13-18)30(35)29-28-22/h1-9,11,13,19,21,31,35H,10,12,14H2,(H,27,32)(H,33,34)	AQBVLIFTZMHBHE-UHFFFAOYSA-N	300738	US10130642, Example 4-34	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300738	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300738&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553963	381749498							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575649	Cc1nc2c(C)cc(cc2[nH]1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C22H25N3O4/c1-13-8-16(11-19-20(13)24-14(2)23-19)21(27)25-18(10-17(12-26)22(28)29)9-15-6-4-3-5-7-15/h3-8,11,17-18,26H,9-10,12H2,1-2H3,(H,23,24)(H,25,27)(H,28,29)	KYLJYJMFFYOMOL-UHFFFAOYSA-N	300739	US10130642, Example 4-35	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300739	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300739&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553964	381749499							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575650	OCC(CC(Cc1ccccc1)NC(=O)c1cc(Cl)c2nc[nH]c2c1)C(O)=O	InChI=1S/C20H20ClN3O4/c21-16-8-13(9-17-18(16)23-11-22-17)19(26)24-15(7-14(10-25)20(27)28)6-12-4-2-1-3-5-12/h1-5,8-9,11,14-15,25H,6-7,10H2,(H,22,23)(H,24,26)(H,27,28)	YNCCMNPBXAWSNZ-UHFFFAOYSA-N	300740	US10130642, Example 4-36	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300740	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300740&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553965	381749500							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575651	Cc1nc2c(Cl)cc(cc2[nH]1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C21H22ClN3O4/c1-12-23-18-10-14(9-17(22)19(18)24-12)20(27)25-16(8-15(11-26)21(28)29)7-13-5-3-2-4-6-13/h2-6,9-10,15-16,26H,7-8,11H2,1H3,(H,23,24)(H,25,27)(H,28,29)	MCEQPWCQZVOKDY-UHFFFAOYSA-N	300741	US10130642, Example 4-38	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300741	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300741&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553966	381749501							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575652	CCc1nc2c(Cl)cc(cc2[nH]1)C(=O)NC(CC(CO)C(O)=O)Cc1ccccc1	InChI=1S/C22H24ClN3O4/c1-2-19-25-18-11-14(10-17(23)20(18)26-19)21(28)24-16(9-15(12-27)22(29)30)8-13-6-4-3-5-7-13/h3-7,10-11,15-16,27H,2,8-9,12H2,1H3,(H,24,28)(H,25,26)(H,29,30)	YFWUPEAGJBEYBV-UHFFFAOYSA-N	300742	US10130642, Example 4-40	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300742	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300742&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553967	381749502							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575653	OCC(CC(Cc1ccccc1)NC(=O)c1ccc2nn[nH]c2n1)C(O)=O	InChI=1S/C18H19N5O4/c24-10-12(18(26)27)9-13(8-11-4-2-1-3-5-11)19-17(25)15-7-6-14-16(20-15)22-23-21-14/h1-7,12-13,24H,8-10H2,(H,19,25)(H,26,27)(H,20,21,22,23)	OAHOHTWPICLCPS-UHFFFAOYSA-N	300743	US10130642, Example 4-43	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300743	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300743&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553968	381749503							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575654	OCC(CC(Cc1ccccc1)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C16H18N2O6/c19-9-11(16(22)23)7-12(6-10-4-2-1-3-5-10)17-15(21)13-8-14(20)18-24-13/h1-5,8,11-12,19H,6-7,9H2,(H,17,21)(H,18,20)(H,22,23)	DUGYEEQPQBOJDD-UHFFFAOYSA-N	300744	US10130642, Example 4-45	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300744	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300744&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553969	381749504							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575655	OCC(CC(Cc1ccccc1)NC(=O)c1cnc(O)nc1)C(O)=O	InChI=1S/C17H19N3O5/c21-10-12(16(23)24)7-14(6-11-4-2-1-3-5-11)20-15(22)13-8-18-17(25)19-9-13/h1-5,8-9,12,14,21H,6-7,10H2,(H,20,22)(H,23,24)(H,18,19,25)	AGWMWLZPQYUIRH-UHFFFAOYSA-N	300745	US10130642, Example 4-47	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300745	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300745&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553970	381749505							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575656	OCC(CC(Cc1ccccc1)NC(=O)c1ccc(O)nn1)C(O)=O	InChI=1S/C17H19N3O5/c21-10-12(17(24)25)9-13(8-11-4-2-1-3-5-11)18-16(23)14-6-7-15(22)20-19-14/h1-7,12-13,21H,8-10H2,(H,18,23)(H,20,22)(H,24,25)	VPJNNHKDMRIKLZ-UHFFFAOYSA-N	300746	US10130642, Example 4-49	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300746	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300746&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553971	381749506							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575657	OCC(CC(Cc1ccccc1)NC(=O)c1cc(=O)c(O)co1)C(O)=O	InChI=1S/C18H19NO7/c20-9-12(18(24)25)7-13(6-11-4-2-1-3-5-11)19-17(23)16-8-14(21)15(22)10-26-16/h1-5,8,10,12-13,20,22H,6-7,9H2,(H,19,23)(H,24,25)	LLFWXRNXNOQIFQ-UHFFFAOYSA-N	300747	US10130642, Example 4-50	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300747	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300747&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553972	381749507							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575658	C[C@@](CO)(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)C1C=NN=N1)C(O)=O |r,c:25,27|	InChI=1S/C22H24N4O4/c1-22(14-27,21(29)30)12-18(24-20(28)19-13-23-26-25-19)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13,18-19,27H,11-12,14H2,1H3,(H,24,28)(H,29,30)	WBYNCGBUTUSYQB-UHFFFAOYSA-N	300748	US10130642, Example 5-A	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300748&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68181156	381749508							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575659	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nnc(Cl)[nH]1)C(O)=O	InChI=1S/C22H23ClN4O4/c1-22(13-28,20(30)31)12-17(24-19(29)18-25-21(23)27-26-18)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,17,28H,11-13H2,1H3,(H,24,29)(H,30,31)(H,25,26,27)	DMMDWQKLTJKDCA-UHFFFAOYSA-N	300749	US10130642, Example 6-1	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300749	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300749&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284452	381749509							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575660	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nnc(O)[nH]1)C(O)=O	InChI=1S/C22H24N4O5/c1-22(13-27,20(29)30)12-17(23-19(28)18-24-21(31)26-25-18)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,17,27H,11-13H2,1H3,(H,23,28)(H,29,30)(H2,24,25,26,31)	YAIAAYATBJRGHX-UHFFFAOYSA-N	300750	US10130642, Example 6-2	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300750	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300750&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136477805	381749510							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575661	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)C1CN=NN1)C(O)=O |c:26|	InChI=1S/C22H26N4O4/c1-22(14-27,21(29)30)12-18(24-20(28)19-13-23-26-25-19)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,18-19,27H,11-14H2,1H3,(H,23,25)(H,24,28)(H,29,30)	QVOXBQOABQMPCO-UHFFFAOYSA-N	300751	US10130642, Example 6-3	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300751	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300751&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553973	381749511							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575662	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C22H24N4O5/c1-22(14-27,21(29)30)12-18(23-20(28)19-13-26(31)25-24-19)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13,18,27,31H,11-12,14H2,1H3,(H,23,28)(H,29,30)	NPKOVKBFRFVHAI-UHFFFAOYSA-N	300752	US10130642, Example 6-4	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300752	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300752&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284929	381749512							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575663	COC(=O)NC(C)(C)CC(=O)OCn1cc(nn1)C(=O)NC(Cc1ccc(cc1)-c1ccccc1)CC(C)(CO)C(O)=O	InChI=1S/C30H37N5O8/c1-29(2,32-28(41)42-4)16-25(37)43-19-35-17-24(33-34-35)26(38)31-23(15-30(3,18-36)27(39)40)14-20-10-12-22(13-11-20)21-8-6-5-7-9-21/h5-13,17,23,36H,14-16,18-19H2,1-4H3,(H,31,38)(H,32,41)(H,39,40)	CIJXHGVOFRMKOW-UHFFFAOYSA-N	300753	US10130642, Example 6-5	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300753	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300753&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553974	381749513							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575664	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cn(Cc2ccccc2)nn1)C(O)=O	InChI=1S/C29H30N4O4/c1-29(20-34,28(36)37)17-25(16-21-12-14-24(15-13-21)23-10-6-3-7-11-23)30-27(35)26-19-33(32-31-26)18-22-8-4-2-5-9-22/h2-15,19,25,34H,16-18,20H2,1H3,(H,30,35)(H,36,37)	ABWHMHWNRJEAOA-UHFFFAOYSA-N	300754	US10130642, Example 6-6	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300754	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300754&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284990	381749514							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575665	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(O)=O)C(O)=O	InChI=1S/C24H25N3O6/c1-24(14-28,23(32)33)13-18(25-21(29)19-12-20(22(30)31)27-26-19)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,12,18,28H,11,13-14H2,1H3,(H,25,29)(H,26,27)(H,30,31)(H,32,33)	GBQHVRDKGABBQU-UHFFFAOYSA-N	300755	US10130642, Example 6-15	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300755&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68181253	381749515							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575666	CC(=O)c1cc([nH]n1)C(=O)NC(Cc1ccc(cc1)-c1ccccc1)CC(C)(CO)C(O)=O	InChI=1S/C25H27N3O5/c1-16(30)21-13-22(28-27-21)23(31)26-20(14-25(2,15-29)24(32)33)12-17-8-10-19(11-9-17)18-6-4-3-5-7-18/h3-11,13,20,29H,12,14-15H2,1-2H3,(H,26,31)(H,27,28)(H,32,33)	SUXJQMJQRXJLPI-UHFFFAOYSA-N	300756	US10130642, Example 6-16	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300756	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300756&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553975	381749516							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575667	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(O)n[nH]1)C(O)=O	InChI=1S/C23H25N3O5/c1-23(14-27,22(30)31)13-18(24-21(29)19-12-20(28)26-25-19)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,12,18,27H,11,13-14H2,1H3,(H,24,29)(H,30,31)(H2,25,26,28)	MEAGGUKEVLEGMQ-UHFFFAOYSA-N	300757	US10130642, Example 6-17	Neprilysin	Human	 3.55								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300757	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300757&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553976	381749517							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575668	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc(O)nc1)C(O)=O	InChI=1S/C24H25N3O5/c1-24(15-28,22(30)31)12-20(27-21(29)19-13-25-23(32)26-14-19)11-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,13-14,20,28H,11-12,15H2,1H3,(H,27,29)(H,30,31)(H,25,26,32)	NRFOJQQJFPAFOH-UHFFFAOYSA-N	300758	US10130642, Example 6-18	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300758&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553977	381749518							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575669	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)C1CC(O)=NO1)C(O)=O |c:27|	InChI=1S/C23H26N2O6/c1-23(14-26,22(29)30)13-18(24-21(28)19-12-20(27)25-31-19)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,18-19,26H,11-14H2,1H3,(H,24,28)(H,25,27)(H,29,30)	LLSSZLRHRKIFRQ-UHFFFAOYSA-N	300759	US10130642, Example 6-19	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300759	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300759&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553978	381749519							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575670	C[C@@](CO)(C[C@@H](Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1cc(n[nH]1)C(O)=O)C(O)=O |r|	InChI=1S/C24H24FN3O6/c1-24(13-29,23(33)34)12-18(26-21(30)19-11-20(22(31)32)28-27-19)9-14-5-7-15(8-6-14)16-3-2-4-17(25)10-16/h2-8,10-11,18,29H,9,12-13H2,1H3,(H,26,30)(H,27,28)(H,31,32)(H,33,34)	CKJLCWWWEXQTLM-UHFFFAOYSA-N	300760	5-[(1R,3S)-3-Carboxy-1-(3&#8242;-fluorobiphenyl-4-ylmethyl)-4-hydroxy-3-methyl-butylcarbamoyl]-1H-pyrazole-3-carboxylic Acid::US10130642, Example 7	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300760	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300760&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			60148599	381749520							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575671	CC(CO)(CC(Cc1ccc(cc1)-c1cccc(F)c1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C22H23FN4O4/c1-22(13-28,21(30)31)11-18(25-20(29)19-12-24-27-26-19)9-14-5-7-15(8-6-14)16-3-2-4-17(23)10-16/h2-8,10,12,18,28H,9,11,13H2,1H3,(H,25,29)(H,30,31)(H,24,26,27)	ZWBWIQRYNATOPM-UHFFFAOYSA-N	300761	US10130642, Example 8-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300761	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300761&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284609	381749521							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575672	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C22H23FN4O4/c1-22(13-28,21(30)31)11-16(25-20(29)19-12-24-27-26-19)10-14-6-8-15(9-7-14)17-4-2-3-5-18(17)23/h2-9,12,16,28H,10-11,13H2,1H3,(H,25,29)(H,30,31)(H,24,26,27)	BOAUMKBGSVYOEB-UHFFFAOYSA-N	300762	US10130642, Example 8-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300762	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300762&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284473	381749522							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575673	CC(CO)(CC(Cc1ccc(cc1)-c1ccc(F)cc1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C22H23FN4O4/c1-22(13-28,21(30)31)11-18(25-20(29)19-12-24-27-26-19)10-14-2-4-15(5-3-14)16-6-8-17(23)9-7-16/h2-9,12,18,28H,10-11,13H2,1H3,(H,25,29)(H,30,31)(H,24,26,27)	HLUKXQLYQBZQNC-UHFFFAOYSA-N	300763	US10130642, Example 8-3	Neprilysin	Human	 35.5								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300763	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300763&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284859	381749523							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575674	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C22H23FN4O5/c1-22(13-28,21(30)31)11-16(24-20(29)19-12-27(32)26-25-19)10-14-6-8-15(9-7-14)17-4-2-3-5-18(17)23/h2-9,12,16,28,32H,10-11,13H2,1H3,(H,24,29)(H,30,31)	IUDVNVGUHZASLS-UHFFFAOYSA-N	300764	US10130642, Example 8-4	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300764	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300764&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284955	381749524							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575675	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1coc(=O)[nH]1)C(O)=O	InChI=1S/C23H23FN2O6/c1-23(13-27,21(29)30)11-16(25-20(28)19-12-32-22(31)26-19)10-14-6-8-15(9-7-14)17-4-2-3-5-18(17)24/h2-9,12,16,27H,10-11,13H2,1H3,(H,25,28)(H,26,31)(H,29,30)	WDCKDKYMVNDNML-UHFFFAOYSA-N	300765	US10130642, Example 8-5	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300765	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300765&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68284262	381749525							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575676	CC(CO)(CC(Cc1ccc(cc1)-c1ccccc1F)NC(=O)C1CNC(=O)O1)C(O)=O	InChI=1S/C23H25FN2O6/c1-23(13-27,21(29)30)11-16(26-20(28)19-12-25-22(31)32-19)10-14-6-8-15(9-7-14)17-4-2-3-5-18(17)24/h2-9,16,19,27H,10-13H2,1H3,(H,25,31)(H,26,28)(H,29,30)	CCHVIAFSPASJBM-UHFFFAOYSA-N	300766	US10130642, Example 8-6	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300766	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300766&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553979	381749526							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575677	CC(C)([C@H](C[C@@H](CO)C(O)=O)NC(=O)c1cn(O)nn1)c1ccc(cc1)-c1ccccc1 |r|	InChI=1S/C23H26N4O5/c1-23(2,18-10-8-16(9-11-18)15-6-4-3-5-7-15)20(12-17(14-28)22(30)31)24-21(29)19-13-27(32)26-25-19/h3-11,13,17,20,28,32H,12,14H2,1-2H3,(H,24,29)(H,30,31)	BRRGRQVGXNANKQ-UHFFFAOYSA-N	300767	(2S,4S)-5-Biphenyl-4-yl-4-[(3-hydroxy-isoxazole-5-carbonyl)-amino]-2-hydroxymethyl-5-methyl-hexanoic Acid::US10130642, Example 9	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300767	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300767&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			68183438	381749527							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575678	CC(C)(C(CC(CO)C(O)=O)Cc1ccc(cc1)-c1ccccc1)C(=O)c1cn(O)nn1	InChI=1S/C24H27N3O5/c1-24(2,22(29)21-14-27(32)26-25-21)20(13-19(15-28)23(30)31)12-16-8-10-18(11-9-16)17-6-4-3-5-7-17/h3-11,14,19-20,28,32H,12-13,15H2,1-2H3,(H,30,31)	RVFMNAJXXRDUCX-UHFFFAOYSA-N	300768	US10130642, Example 10-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300768	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300768&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553980	381749528							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
575679	CC(C)(C(CC(CO)C(O)=O)Cc1ccc(cc1)-c1ccccc1)C(=O)c1cnn[nH]1	InChI=1S/C24H27N3O4/c1-24(2,22(29)21-14-25-27-26-21)20(13-19(15-28)23(30)31)12-16-8-10-18(11-9-16)17-6-4-3-5-7-17/h3-11,14,19-20,28H,12-13,15H2,1-2H3,(H,30,31)(H,25,26,27)	NRMJOVFNBVYCRO-UHFFFAOYSA-N	300769	US10130642, Example 10-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q29Z96ZH		aid1796058	US10130642	Fleury, M; Gendron, R; Hughes, AD	11/20/2018	3/28/2019	Theravance Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300769	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300769&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137553981	381749529							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4